Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations

AIDS
Haruhiko MurataM Mueckler

Abstract

To determine the relative sensitivities of glucose transporter isoforms to the protease inhibitor indinavir and to determine the kinetic mechanism of indinavir-mediated Glut4 isoform inhibition. The rate of 2-deoxyglucose uptake was measured in Xenopus laevis oocytes heterologously expressing mammalian Glut isoforms. 2-Deoxyglucose uptake was also measured in 3T3-L1 fibroblasts, 3T3-L1 adipocytes, and primary rat adipocytes. The sensitivity to inhibition by indinavir among the Glut isoforms as assayed in the X. laevis oocyte system was as follows in decreasing order: Glut4 > Glut2 > Glut3 > Glut1 approximately Glut8. 2-Deoxyglucose uptake measurements in insulin-stimulated primary rat adipocytes indicated a non-competitive mode of transport inhibition by indinavir under zero-trans conditions with a KI of 15 microM. Indinavir appears to be a relatively selective inhibitor of the Glut4 isoform. As the concentration required to significantly inhibit insulin-stimulated glucose uptake in primary rat adipocytes is well within the physiologic range achieved in therapy, we conclude that direct inhibition of Glut4 contributes to the insulin resistance observed in patients receiving this drug.

References

Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·K M TordjmanM M Mueckler
May 12, 2000·The Journal of Biological Chemistry·H MurataM Mueckler
Nov 23, 2000·AIDS·P L AndersonC V Fletcher
Mar 20, 2001·American Journal of Physiology. Endocrinology and Metabolism·P W HruzM Mueckler
Jul 13, 2001·Antiviral Research·R G JainJ M Lenhard

❮ Previous
Next ❯

Citations

Apr 8, 2004·Current Atherosclerosis Reports·Rajagopal V SekharAshok Balasubramanyam
Aug 11, 2005·Current HIV/AIDS Reports·Grace A LeeCarl Grunfeld
Mar 19, 2003·Current Hypertension Reports·Nasser Mikhail
Nov 13, 2004·Current Infectious Disease Reports·Grace A LeeCarl Grunfeld
Dec 3, 2011·Endocrine·Absalon D Gutierrez, Ashok Balasubramanyam
Sep 11, 2003·The Lancet Oncology·Cecilia SgadariBarbara Ensoli
Sep 25, 2010·The Journal of Biological Chemistry·Arpita Kalla VyasPaul W Hruz
Oct 22, 2004·The Journal of Biological Chemistry·Johann HertelPaul W Hruz
Jun 8, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bruno LedergerberUNKNOWN Swiss HIV Cohort Study
Nov 1, 2003·AIDS Patient Care and STDs·Kimberly Y SmithDiana Williamson
Apr 29, 2005·AIDS Patient Care and STDs·Michael L TapperCorklin Steinhart
Mar 29, 2008·Metabolic Syndrome and Related Disorders·Bruno FèveKhadija El Hadri
Mar 29, 2002·AIDS·Carl Grunfeld
Aug 19, 2004·AIDS·Grace A McComsey, Ethan Leonard
Aug 19, 2004·AIDS·Jean-Marc SchwarzCarl Grunfeld
May 29, 2004·Current Opinion in Lipidology·Ashok BalasubramanyamHenry J Pownall
Apr 12, 2005·AIDS·Daniel S Kamin, Steven K Grinspoon
Nov 11, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Qingyun Yan, Paul W Hruz
Aug 15, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Grace A LeeCarl Grunfeld
May 19, 2009·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Amira Klip
Sep 1, 2005·American Journal of Physiology. Endocrinology and Metabolism·C HadiganS Grinspoon
Feb 12, 2009·American Journal of Physiology. Endocrinology and Metabolism·Sheng ZhangSasanka Ramanadham
Jun 12, 2012·Cardiovascular Diabetology·Lauren Aerni-FlessnerPaul W Hruz
Apr 24, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kyriaki BakirtziKonstantin V Kandror
Apr 22, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andrea A HowardEllie E Schoenbaum
Aug 21, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Paul E Sax, Princy Kumar
Dec 17, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Cecilia YoonMarshall J Glesby
Nov 30, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Paul W Hruz, Qingjun Yan
Nov 20, 2009·Scandinavian Journal of Infectious Diseases·Anne Maagaard, Dag Kvale
Dec 14, 2007·Expert Opinion on Pharmacotherapy·Georg Mn Behrens
May 22, 2010·Expert Opinion on Pharmacotherapy·Rajagopal V Sekhar, Ashok Balasubramanyam
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Steen B Haugaard
Nov 1, 2005·Expert Opinion on Drug Safety·Hassane IzzedineGilbert Deray

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.